Davis Quoted on Court Ruling Bolstering New Type of 'Poison Pill'
May 7, 2014
Wall Street Journal
Partner Gardner Davis was quoted in a Wall Street Journal article published on May 7, 2014, titled “Court Ruling Bolsters New Type of ‘Poison Pill.’” The article discussed a recent decision made by the Delaware Court of Chancery that affirmed the legality of a new type of “poison pill,” a tactic used by a company threatened with an unwelcome takeover bid to make itself unattractive to the bidder. This new arrangement has found favor among companies seeking protection from activist investors. Davis was quoted saying, “If I’m the general counsel of a public company and I’m worried about an activist investor—and these days, everybody is worried—this is…a nice tool to have on the shelf.”
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."
June 4, 2025
In the News
Foley Attorneys Explore IP Considerations for AI-Generated Logos
Foley & Lardner LLP attorneys Von Bryant, Norm Rich, and Alex Liederman authored the Bloomberg Law article, "AI-Generated Logos Require Careful Steps to Protect IP Rights."